Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Background and FDAs Announcement FDA's April 1, 2026, update to its compounding policy page follows more than 18 months of regulatory activity surrounding the compounding of GLP-1 medications, primarily semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound)
Participants on 15 mg tirzepatide lost an average of 14.7% body weight compared to 3.2% with placebo, while those on 10 mg lost 13.4%
Thus it is possible that combining them will result in more significant results than using them alone
However, other factors such as cost, side effects, and individual response to the medications should also be taken into consideration when making a decision
Veterinarians recommend that treats should be no more than 10% of a pet's daily calories 7
Special Considerations in Dosing Semaglutide's dosing guidelines provide a general plan, but it's important to consider each patients needs
